QUOTE AND NEWS
Market Intelligence Center  Apr 10  Comment 
After Thursday’s trading in Achillion Pharmaceuticals, Inc. (ACHN) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 14.38% or 18.74% (for comparison purposes only), while providing 40.12% downside...
Benzinga  Apr 9  Comment 
In a report published Thursday, JMP Securities analysts expressed their views on Biotechnology stocks after the EASL abstracts were made available ahead of the European liver meeting. The analysts have a Market Perform rating on Merck & Co. Inc...
Motley Fool  Apr 1  Comment 
Achillion Pharmaceuticals' ACH-3102 and ACH-3422 could eventually offer up an alternative to Gilead Sciences' HCV medicines.
Motley Fool  Mar 22  Comment 
Achillion Pharmaceuticals has a big opportunity in hepatitis C, but it also faces some risks.
Motley Fool  Mar 18  Comment 
Achillion Pharmaceuticals Inc. is working on a promising hepatitis C therapy that could reduce treatment times.
TheStreet.com  Mar 5  Comment 
NEW YORK (TheStreet) -- Shares of Achillion Pharmaceuticals are sliding, down 7.48% to $10.76 on heavy volume in afternoon trading Thursday. This morning, the company posted its fourth quarter 2014 earnings results. Achillion posted a loss of...
Benzinga  Mar 4  Comment 
Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham. Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at Underweight with an...





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki